KIF6 Statin Benefit Genotype Add-On

About the Test

This test detects variations in the KIF6 gene. It identifies individuals with a gene variant associated with an increased risk of coronary heart disease (CHD). Carriers have enhanced CHD risk reduction when treated with statin therapy. This test can be added to any other Boston Heart genetics test. Please be advised that Boston Heart Diagnostics policy states that practitioners are unable to order labs on themselves or their immediate family members.

Biomarkers

KIF6

Biomarker name

Related Articles

Related Tests

Lipid Panel

 by 

Access Med Labs

Serum

The Lipid Panel is used to analyze a patient's risk of cardiovascular disease.

C-Reactive Protein, High Sensitivity (CRP, HS)

 by 

Access Med Labs

Serum

This is a single-marker test measuring hs-CRP. It is used to assess cardiovascular disease risk.

Homocysteine

 by 

Access Med Labs

Serum

This is a single-marker test measuring homocysteine. It can be used to screen patients who may be at risk for heart disease and stroke.

Lipid Panel

 by 

Labcorp

Serum

The Lipid Panel is used to analyze a patient's risk of cardiovascular disease.

C-Reactive Protein, High Sensitivity (CRP, HS)

 by 

Labcorp

Serum

This is a single-marker test measuring hs-CRP. It can be used to help assess the risk of cardiovascular and peripheral vascular disease.